Want to see NKTR full AI Analyst Report?
Nektar Therapeutics (NKTR) Ownership Overview
2.95% Insiders
13.67% Mutual Funds
48.30% Other Institutional Investors
12.27% ETFs
22.81% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 74.24% of the company’s stock is owned by Institutional Investors, 2.95% is owned by Insiders, and 22.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 20, 2026 | xxxxxxxxxxxxx | $13388 | |
Aug 20, 2026 | xxxxxxxxxxxxx | $30088 | |
May 21, 2026 | xxxxxxxxxxxxx | $13036 | |
May 21, 2026 | xxxxxxxxxxxxx | $29086 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $19047659 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $32871784 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $41946944 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $2829748 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,807,603 | Institution | 5.29% | 127,707,152 | |
| 1,743,075 | Institution | 5.11% | 123,148,249 | |
| 1,431,067 | Institution | 4.19% | 101,104,884 | |
| 1,168,405 | Institution | 3.42% | 82,547,813 | |
| 600,873 | Institution | 1.76% | 42,451,677 | |
| 470,875 | Institution | 1.38% | 33,267,319 | |
| 308,361 | Institution | 0.90% | 21,785,705 | |
| 303,574 | Insider | 0.89% | 21,447,503 | |
| 290,569 | Institution | 0.85% | 20,528,700 | |
| 287,750 | Insider | 0.84% | 20,329,538 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,743,075 | Institution | 5.11% | 123,148,249 | |
| 1,168,405 | Institution | 3.42% | 82,547,813 | |
| 290,569 | Institution | 0.85% | 20,528,700 | |
| 273,886 | Institution | 0.80% | 19,350,046 | |
| 266,881 | Institution | 0.78% | 18,855,143 | |
| 246,334 | Institution | 0.72% | 17,403,497 | |
| 104,721 | Institution | 0.31% | 7,398,539 | |
| 90,281 | Institution | 0.26% | 6,378,353 | |
| 90,000 | Institution | 0.26% | 6,358,500 | |
| 72,788 | Institution | 0.21% | 5,142,472 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,079,340 | Institution | 3.16% | 76,276,958 | |
| 874,409 | Institution | 2.56% | 61,776,996 | |
| 389,642 | Institution | 1.14% | 27,536,000 | |
| 289,334 | Institution | 0.85% | 20,441,447 | |
| 193,427 | Institution | 0.57% | 13,669,486 | |
| 168,569 | Institution | 0.49% | 12,359,479 | |
| 161,077 | Institution | 0.47% | 11,810,166 | |
| 125,055 | Institution | 0.37% | 8,835,136 | |
| 93,054 | Institution | 0.27% | 6,576,126 | |
| 64,133 | Institution | 0.19% | 4,702,232 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 48.30% of the company's stock is held by institutional investors, 2.95% is held by insiders, and 22.81% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.30% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.81% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
Vanguard owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.